BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18505476)

  • 1. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
    Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
    J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts.
    Dib C; Bou Saada Y; Dmitriev P; Richon C; Dessen P; Laoudj-Chenivesse D; Carnac G; Lipinski M; Vassetzky YS
    J Cell Physiol; 2016 Jan; 231(1):62-71. PubMed ID: 26218298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
    Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
    Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression during normal and FSHD myogenesis.
    Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
    BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
    Cheli S; François S; Bodega B; Ferrari F; Tenedini E; Roncaglia E; Ferrari S; Ginelli E; Meneveri R
    PLoS One; 2011; 6(6):e20966. PubMed ID: 21695143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy.
    Banerji CRS; Panamarova M; Pruller J; Figeac N; Hebaishi H; Fidanis E; Saxena A; Contet J; Sacconi S; Severini S; Zammit PS
    Hum Mol Genet; 2019 Apr; 28(8):1244-1259. PubMed ID: 30462217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
    Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
    PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress.
    Winokur ST; Barrett K; Martin JH; Forrester JR; Simon M; Tawil R; Chung SA; Masny PS; Figlewicz DA
    Neuromuscul Disord; 2003 May; 13(4):322-33. PubMed ID: 12868502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
    Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
    Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.
    Nguyen TH; Paprzycki L; Legrand A; Declèves AE; Heher P; Limpens M; Belayew A; Banerji CRS; Zammit PS; Tassin A
    Skelet Muscle; 2023 Dec; 13(1):21. PubMed ID: 38104132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
    Vilquin JT; Marolleau JP; Sacconi S; Garcin I; Lacassagne MN; Robert I; Ternaux B; Bouazza B; Larghero J; Desnuelle C
    Gene Ther; 2005 Nov; 12(22):1651-62. PubMed ID: 15973444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.
    Dmitriev P; Stankevicins L; Ansseau E; Petrov A; Barat A; Dessen P; Robert T; Turki A; Lazar V; Labourer E; Belayew A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    J Biol Chem; 2013 Dec; 288(49):34989-5002. PubMed ID: 24145033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSHD myotubes with different phenotypes exhibit distinct proteomes.
    Tassin A; Leroy B; Laoudj-Chenivesse D; Wauters A; Vanderplanck C; Le Bihan MC; Coppée F; Wattiez R; Belayew A
    PLoS One; 2012; 7(12):e51865. PubMed ID: 23272181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.
    Ansseau E; Laoudj-Chenivesse D; Marcowycz A; Tassin A; Vanderplanck C; Sauvage S; Barro M; Mahieu I; Leroy A; Leclercq I; Mainfroid V; Figlewicz D; Mouly V; Butler-Browne G; Belayew A; Coppée F
    PLoS One; 2009 Oct; 4(10):e7482. PubMed ID: 19829708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.